We tweeted about this article publishing in Circular Research, April 27, 2018, Volume 122, Issue 9: How do our individual genomes and life histories influence our well-being, risk for diseases, and responses to medical treatments? This is the fundamental question precision medicine seeks to address.
Understand how the confluence of genes and environment defines pathophysiological traits, and we can, in theory, prescribe the most suitable treatments to each individual, better predict population health to improve policy-making, and perhaps even unlock some of the mysteries behind the circuitry of life itself. Read the article and dowload the Circular Research PDF >>
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
